. Author manuscript; available in PMC: 2012 Nov 13.

Published in final edited form as: Macromol Biosci. 2011 Jul 25;11(10):1370–1377. doi: 10.1002/mabi.201100107

Table 2.

Poly(α-methyl-β, L-malate) (PAALM-1) NPs encapsulation of TMZ and DOX.

Substance	Encapsulation^a) [wt%]	Encapsulation efficiency^b) [wt%]
TMZ	2.18 ± 0.17	21.75 ± 1.7
DOX	4.20 ± 0.62	42.06 ± 6.2

^a)

Percentage of drug contained in the NPs upon encapsulation;

^b)

Percentage of the drug that is encapsulated.